]]> Finance Search Sat, Aug 23, 2014, 1:39PM EDT – U.S. Markets closed Dow 0.22% Nasdaq 0.14% More On GBLX Quotes Summary Order Book Options Historical Prices Charts...
GB Sciences aims to help people who currently suffer from a variety of poorly-controlled medical conditions by creating consistent and efficacious medical-grade cannabis and specialized cannabis therapies using our proprietary technology and proven quality control processes.
GB Sciences, Inc. is effectively creating solutions for the challenges of the emerging medical marijuana industry that can be replicated in every state in which medical marijuana is legal. These GrowBLOX™ Solutions include: State Licensing, Superior Genetics, Medical Product Development, Research and Clinical Trials, Tissue Propagation, Cultivation, Curing Products, and Conversion Labs. Our solutions combine both technological advancements (i.e. GrowBLOX™ Cultivation chambers) as well as procedural validations (i.e., medical marijuana establishment licensing). Our flagship operations are in Las Vegas, NV, but our proprietary technology and validated procedures will be implemented through state-level partners to create marijuana therapies with consistent results and industry-leading quality control.
While still in its infancy, the medical marijuana industry is growing rapidly. With growth will come increased regulation designed to ensure the safety and effectiveness of cannabis-based products used for medicinal purposes. As a result, GrowBLOX Sciences, Inc. is a pioneer in the “medical” marijuana industry today through its system of technology and procedures designed to ensure consistency in both safety and effectiveness. GB Sciences exceeds all current national regulations and hopes to have a role in setting the new gold standard for the medical marijuana industry.
Recent (GBLX) Corporate News:
GB Sciences, Inc. CEO Craig Ellins to Present on the Medical Marijuana Stocks Public Company Panel at The Money Show: Tune in and View it Live
LAS VEGAS, Aug. 21, 2014 (GLOBE NEWSWIRE) — GrowBLOX Sciences, Inc. (GBLX), a medical marijuana research and development company, announced that CEO Craig Ellins will be...
LAS VEGAS, Aug. 15, 2014 (GLOBE NEWSWIRE) — GrowBLOX Sciences, Inc. (GBLX) a medical marijuana research and development company, announced they have completed and officially...